In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-10 of 10 for your search:
Drug:  nelfinavir mesylate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04090, NCI-2010-01263, CDR0000438712, FDA R01FD003006-03, CHNMC-04090, NCT00233948

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MEC 07-03-026, NCT00704600

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065583, E1D95, AMC-014, NCT00003008

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 200905704, NCT01065844

5.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-07-C-0047, NCI-P6880, NCT00436735

6.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 441-07, NCI-2009-01443, P30CA036727, UNMC-44107, UNMC-441-07-FB, NCT00705393, NCT01068327

7.

Phase: Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 07-09-04/07, EudraCT number 2008-001078-34, NCT00694837

8.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 01309, NCT01020292

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AMCmedonc09/039, NCT01079286

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 65/08, SWS-SAKK-65/08, EU-21051, SWS-SAKK-JC26866138LYM1005, CDR0000681442, NCT01164709
New Search